$15.2B
$156 Million
0.01% of portfolio
853,545
Q1 2025
Reduced 0.02%
$12.8B
$71.8 Million
0.01% of portfolio
1,137,559
Q1 2025
Added 41.31%
$15.1B
$97.6 Million
0.01% of portfolio
4,708,204
Q1 2025
Added 62.89%
$15.2B
$112 Million
0.01% of portfolio
1,042,003
Q1 2025
Added 18.2%
$16.7B
$93.7 Million
0.01% of portfolio
331,664
Q1 2025
Reduced 15.01%
$20B
$132 Million
0.01% of portfolio
1,168,076
Q1 2025
Reduced 5.75%
$19.4B
$68.9 Million
0.01% of portfolio
933,324
Q1 2025
Added 49.77%
$45.3B
$90 Million
0.01% of portfolio
453,524
Q1 2025
Added 29.92%
$41.3M
$31,000
0.0% of portfolio
8,000
Q4 2023
Reduced 4.0%
$1.15B
$23.3 Million
0.0% of portfolio
2,667,389
Q1 2025
Added 307.24%
$202M
$227,000
0.0% of portfolio
38,524
Q1 2025
Reduced 32.86%
-
$0
0.0% of portfolio
-
Q4 2024
Added 128.57%
$1.6B
$1.19 Million
0.0% of portfolio
19,890
Q1 2025
Reduced 24.79%
$105M
$60,000
0.0% of portfolio
19,754
Q1 2025
Reduced 25.78%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 99.44%
$189M
$12.4 Million
0.0% of portfolio
2,516,505
Q1 2025
Added 0.02%
$25.3M
$10,000
0.0% of portfolio
30,605
Q1 2025
Reduced 39.46%
-
$0
0.0% of portfolio
-
Q1 2025
Added 33.33%
$236M
$1.37 Million
0.0% of portfolio
646,399
Q1 2025
Reduced 8.96%
$132M
$2.26 Million
0.0% of portfolio
698,308
Q1 2025
Added 81.44%
5 E Advanced Materials Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
60 Degrees Pharmaceuticals I
-
$0
0.0% of portfolio
-
Q1 2025
New
$471M
$5.68 Million
0.0% of portfolio
781,952
Q1 2025
Added 118.07%
$225M
$8.58 Million
0.0% of portfolio
4,290,735
Q1 2025
Added 13.06%
$202M
$505,000
0.0% of portfolio
112,906
Q1 2025
Added 19.16%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 20.36%
$1.42B
$2.1 Million
0.0% of portfolio
128,413
Q1 2025
Reduced 29.43%
$4.08B
$26.9 Million
0.0% of portfolio
344,684
Q1 2025
Added 27.51%
$2.59B
$14.1 Million
0.0% of portfolio
252,567
Q1 2025
Added 47.52%
Aardvark Therapeutics Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 9.6%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 58.36%
-
$0
0.0% of portfolio
-
Q1 2025
New
$0
$227,000
0.0% of portfolio
3,469
Q1 2025
New
$0
$239,000
0.0% of portfolio
6,698
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 62.12%
$1.2B
$35,000
0.0% of portfolio
15,975
Q1 2025
Reduced 6.8%
$34.8M
$616,000
0.0% of portfolio
129,415
Q1 2025
Reduced 51.06%
$4.3B
$24 Million
0.0% of portfolio
314,430
Q1 2025
Added 187.82%
-
$0
0.0% of portfolio
-
Q1 2025
Added 93.39%
-
$0
0.0% of portfolio
-
Q1 2025
New
$3.23B
$33 Million
0.0% of portfolio
696,038
Q1 2025
Added 2.69%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 97.76%
Abrdn Asia Pacific Income Fu
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 16.34%
$0
$29,000
0.0% of portfolio
7,356
Q1 2025
Reduced 39.15%
$0
$417,000
0.0% of portfolio
84,163
Q1 2025
Reduced 0.09%
$0
$41 Million
0.0% of portfolio
1,909,758
Q1 2025
Reduced 4.92%
-
$0
0.0% of portfolio
-
Q1 2025
New